 |
||
 |
||
|
How to Obtain AMA PRA Category 1 Credit™
|
|
 |
||
Volume 77, Number 8
How to prevent glucocorticoid-induced osteoporosis
First Step: Review Information Below to Begin Activity
Release Date: August 1, 2010
Expiration Date: July 31, 2011
Description
Each learning activity within the Cleveland Clinic Journal of Medicine CME series is based on an article from the Cleveland Clinic Journal of Medicine, a post-test, and an evaluation.
Objective
Readers will take steps to prevent and treat bone loss in their patients receiving long-term glucocorticoids.
Target Audience
Directed to internists, cardiologists, and other physicians.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity DirectorBrian F. Mandell, MD, PhDChairman, Department of Medicine, Education Institute Professor of Medicine, Cleveland Clinic Lerner College of Medicine Editor-in-Chief, Cleveland Clinic Journal of Medicine Cleveland Clinic Cleveland, OH |
Co-Activity DirectorTimothy Gilligan, MDTaussig Cancer Institute and Department of Bioethics Deputy Editor, Cleveland Clinic Journal of Medicine Cleveland Clinic Cleveland, OH |
Authors / Faculty
| Robin K. Dore, MD Division of Rheumatology, David Geffen School of Medicine at UCLA, Tustin, CA |
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
| Brian F. Mandell, MD, PhD (Activity Director) | ||
| Fees for consulting and speaking (CME lectures): | Takeda Pharmaceuticals |
|
| Paid independent contractor (clinical trials): | Savient Pharmaceuticals | |
| Consultant: | URL Pharma | |
| Section editor (rheumatology and immunology): | The Merck Manual | |
| Robin K. Dore, MD | Honoraria and fees for consulting, teaching, speaking, advisory and review committees: | Amgen, Eli Lilly, Genentech, Novartis, and Procter and Gamble
|
| Phillip E. Canuto (Executive Editor) | ||
| Ownership interest (common stock): | Merck and Medco | |
The following faculty have indicated they have no relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
Timothy Gilligan, MD (Co-Activity Director)
All other CCJM staff report no relevant financial relationships.
Next Step:
(Article opens in new tab / window; return to this window to complete the activity).
Final Step:
Proceed to Posttest and Complete the CME Process
This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.
